CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 207,347	$ 185,574
Restricted cash	3,292	297
Inventories	4,679	2,866
Prepaid expenses and other current assets	18,432	24,656
Total current assets	579,649	538,811
Property and equipment, net (accumulated depreciation of 33,598 and 31,696 as of March 31, 2026 and December 31, 2025, respectively)	94,927	94,581
Operating lease right-of-use assets	26,554	26,955
Financing lease right-of-use assets	220,696	222,367
Intangible assets, net	20,905	21,230
Goodwill, net	13,919	13,919
Other assets	668	662
Total assets	957,318	918,525
Current liabilities:
Lines of credit	146	740
Current portion of long-term debt	16,728	13,336
Operating lease liabilities, current portion	2,176	2,152
Financing lease liabilities, current portion	7,364	7,077
Accrued arbitration expenses	56,833	49,743
Accrued income tax expense	15,594	867
Accrued stock-based compensation	2,723	8,256
Accrued expenses and other current liabilities	32,500	26,773
Total current liabilities	184,436	157,911
Long-term debt, net	24,261	29,174
Non-current operating lease liabilities, net	29,633	30,037
Non-current financing lease liabilities, net	268,778	268,877
Deferred tax liabilities	8,157	9,089
Total liabilities	515,265	495,088
Commitments and contingencies (Note 10)
Equity:
Common stock, $0.001 par value; 950,000,000 shares authorized; 6,951,622 and 5,511,452 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively	7	7
Additional paid-in capital	585,666	615,627
Accumulated deficit	(239,380)	(286,187)
Nutex Health Inc. equity	346,293	329,447
Noncontrolling interests	95,760	93,990
Total equity	442,053	423,437
Total liabilities and equity	957,318	918,525
Nonrelated Party
Current assets:
Accounts receivable	339,560	319,440
Current liabilities:
Accounts payable	46,452	45,863
Related Party
Current assets:
Accounts receivable	6,339	5,978
Current liabilities:
Accounts payable	$ 3,920	$ 3,104